Surveyor Capital - Massinvestor Venture Capital and Private Equity Database

HF Surveyor Capital

https://www.citadel.com/investment-strategies /surveyor-capital/

Office Locations:

300 Crescent Court, Suite 250
Dallas, TX 75201
Phone: 972-892-1700

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.

Stages:

Early

Industries:

Life Sciences & Healthcare

Medical Device

Description:

Established in 2008, Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel Investment's three fundamental equities businesses. Surveyor's independent sector-aligned portfolio teams take a diligent, bottom-up investment approach. Citadel invests in companies in the Communications, Consumer, Energy, Financials, Healthcare, Industrials, Media and Entertainment, and Technology sectors. The team is made up of over 175 investment professionals.

Investment Firm Key

   VC = Venture Capital
   PE = Private Equity
   A = Angel
   I = Incubator
   MB = Merchant Bank
   VD = Venture Debt
   FI = Family Investment Office
   FOF = Fund of Funds
   ED = Economic Development Office
   TT = Technology Transfer Office
   CVC = Corporate Venture Capital
   SEC = Secondary Purchaser
   HF = Hedge Fund/Mutual Fund

COMPANY STAGE	REVENUE
Venture Capital
Seed Stage (includes "pre-seed," or concept stage)	No Revenue
Early Stage	Minimal Revenue
Growth Stage (also called Mid-stage)	$2M-$7M
Expansion Stage (also called Late-stage)	$7M and greater
Private Equity
Lower Middle Market	$10M-$249M
Middle Market	$250M-$499M
Upper Middle Market	$500M-$1B
Large Cap	>$1B

Click Here for a
FREE DEMO
of the #1 VC & PE
Database

▶ 5,000 Firms

▶ 18,000 Partner Emails

▶ 30,000 Portfolio
companies

Investment Team:

Name	Title	Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
James Yeh	President and Co-Chief Investment Officer
Todd Barker	Head of Surveyor Capital

Recent Funding Events (trailing 12 months):

Date	Name	State	Amount	Stage
04/03/2024	Obsidian Therapeutics	MA	$160,500,000	Series C
02/13/2024	ProfoundBio	WA	$112,000,000	Series B
12/20/2023	Sudo Biosciences	CA	$116,000,000	Series B
09/29/2023	Avalyn Pharma	WA	$175,000,000	Series C
09/07/2023	Mariana Oncology	MA	$175,000,000	Series B
08/23/2023	Rapport Therapeutics	MA	$150,000,000	Series B
05/24/2023	ElevateBio	MA	$401,000,000	Series D
05/22/2023	Quanta Therapeutics	CA	$50,700,000	Series D